Proteomic identification of nitrated proteins in Alzheimer's disease brain

被引:461
作者
Castegna, A
Thongboonkerd, V
Klein, JB
Lynn, B
Markesbery, WR
Butterfield, DA [1 ]
机构
[1] Univ Kentucky, Dept Chem, Ctr Membrane Sci, Lexington, KY 40506 USA
[2] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA
[3] Univ Kentucky, Core Proteom Lab, Lexington, KY 40506 USA
[4] Univ Kentucky, Dept Pathol & Neurol, Lexington, KY 40506 USA
[5] Univ Louisville, Sch Med, Kidney Dis Program, Louisville, KY 40292 USA
[6] Univ Louisville, Sch Med, Proteom Core Lab, Louisville, KY 40292 USA
[7] VAMC, Louisville, KY USA
关键词
Alzheimer's disease; neurodegeneration; 3-nitrotyrosine; proteomics; reactive nitrogen species;
D O I
10.1046/j.1471-4159.2003.01786.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nitration of tyrosine in biological conditions represents a pathological event that is associated with several neurodegenerative diseases, such as amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease (AD). Increased levels of nitrated proteins have been reported in AD brain and CSF, demonstrating the potential involvement of reactive nitrogen species (RNS) in neurodegeneration associated with this disease. Reaction of NO with leads to formation of peroxynitrite ONOO- , which following protonation, generates cytotoxic species that oxidize and nitrate proteins. Several findings suggest an important role of protein nitration in modulating the activity of key enzymes in neurodegenerative disorders, although extensive studies on specific targets of protein nitration in disease are still missing. The present investigation represents a further step in understanding the relationship between oxidative modification of protein and neuronal death in AD. We previously applied a proteomics approach to determine specific targets of protein oxidation in AD brain, by successfully coupling immunochemical detection of protein carbonyls with two-dimensional polyacrylamide gel electrophoresis and mass spectrometry analysis. In the present study, we extend our investigation of protein oxidative modification in AD brain to targets of protein nitration. The identification of six targets of protein nitration in AD brain provides evidence to the importance of oxidative stress in the progression of this dementing disease and potentially establishes a link between RNS-related protein modification and neurodegeneration.
引用
收藏
页码:1394 / 1401
页数:8
相关论文
共 45 条
[1]   Oxidative modification of creatine kinase BB in Alzheimer's disease brain [J].
Aksenov, M ;
Aksenova, M ;
Butterfield, DA ;
Markesbery, WR .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (06) :2520-2527
[2]   Protein oxidation in the brain in Alzheimer's disease [J].
Aksenov, MY ;
Aksenova, MV ;
Butterfield, DA ;
Geddes, JW ;
Markesbery, WR .
NEUROSCIENCE, 2001, 103 (02) :373-383
[3]  
[Anonymous], 1997, Neurobiol Aging, V18, pS1
[4]   Proteomic method identifies proteins nitrated in vivo during inflammatory challenge [J].
Aulak, KS ;
Miyagi, M ;
Yan, L ;
West, KA ;
Massillon, D ;
Crabb, JW ;
Stuehr, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (21) :12056-12061
[5]   Oxidative damage and tyrosine nitration from peroxynitrite [J].
Beckman, JS .
CHEMICAL RESEARCH IN TOXICOLOGY, 1996, 9 (05) :836-844
[6]   Peroxynitrite-mediated nitration of tyrosine residues in Escherichia coli glutamine synthetase mimics adenylylation: Relevance to signal transduction. [J].
Berlett, BS ;
Friguet, B ;
Yim, MB ;
Chock, PB ;
Stadtman, ER .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) :1776-1780
[7]  
Butterfield D.A., 1997, ADV CELL AGING GERON, V2, P161
[8]  
Butterfield DA, 2002, NEUROBIOL AGING, V23, P655
[9]   Amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity:: Implications for neurodegeneration in Alzheimer's disease brain.: A review [J].
Butterfield, DA .
FREE RADICAL RESEARCH, 2002, 36 (12) :1307-1313
[10]   Evidence of oxidative damage in Alzheimer's disease brain:: central role for amyloid β-peptide [J].
Butterfield, DA ;
Drake, J ;
Pocernich, C ;
Castegna, A .
TRENDS IN MOLECULAR MEDICINE, 2001, 7 (12) :548-554